Viewing Study NCT02725918


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2026-03-01 @ 12:23 AM
Study NCT ID: NCT02725918
Status: UNKNOWN
Last Update Posted: 2020-02-12
First Post: 2016-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pemetrexed vs Pemetrexed Plus Cisplatin in EGFR-mutant NSCLC Patients After First Line EGFR-TKIs Failure
Sponsor: Guangdong Association of Clinical Trials
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC View
None EGFR-TKI failure View
None chemotherapy View